DK1155012T3 - Dihydroquinazolinderivater med anti-cancer-aktivitet - Google Patents

Dihydroquinazolinderivater med anti-cancer-aktivitet

Info

Publication number
DK1155012T3
DK1155012T3 DK00905212T DK00905212T DK1155012T3 DK 1155012 T3 DK1155012 T3 DK 1155012T3 DK 00905212 T DK00905212 T DK 00905212T DK 00905212 T DK00905212 T DK 00905212T DK 1155012 T3 DK1155012 T3 DK 1155012T3
Authority
DK
Denmark
Prior art keywords
cancer activity
dihydroquinazoline derivatives
dihydroquinazoline
derivatives
formulawhere
Prior art date
Application number
DK00905212T
Other languages
Danish (da)
English (en)
Inventor
Lorraine Skelton
Vassilis Bavetsias
Ann Crc Jackman
Original Assignee
Cancer Rec Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Rec Tech Ltd filed Critical Cancer Rec Tech Ltd
Application granted granted Critical
Publication of DK1155012T3 publication Critical patent/DK1155012T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK00905212T 1999-02-24 2000-02-24 Dihydroquinazolinderivater med anti-cancer-aktivitet DK1155012T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9904275.6A GB9904275D0 (en) 1999-02-24 1999-02-24 Anti-cancer compounds
PCT/GB2000/000655 WO2000050417A1 (en) 1999-02-24 2000-02-24 Anti-cancer dihydroquinazoline derivatives

Publications (1)

Publication Number Publication Date
DK1155012T3 true DK1155012T3 (da) 2004-08-09

Family

ID=10848434

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00905212T DK1155012T3 (da) 1999-02-24 2000-02-24 Dihydroquinazolinderivater med anti-cancer-aktivitet

Country Status (11)

Country Link
US (1) US6699861B1 (de)
EP (1) EP1155012B1 (de)
JP (1) JP2002537391A (de)
AT (1) ATE264322T1 (de)
AU (1) AU772670B2 (de)
CA (1) CA2364708A1 (de)
DE (1) DE60009868T2 (de)
DK (1) DK1155012T3 (de)
ES (1) ES2219308T3 (de)
GB (1) GB9904275D0 (de)
WO (1) WO2000050417A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1421105E (pt) * 2001-08-31 2010-12-07 Btg Int Ltd Compostos anticancerígenos de ciclopenta-g quinazolina
WO2003020300A1 (en) 2001-08-31 2003-03-13 Btg International Limited Use of cyclopenta[g]quinazoline derivatives for treating cancer
GB0121214D0 (en) 2001-08-31 2001-10-24 Btg Int Ltd Synthetic method
US20030119834A1 (en) * 2001-09-05 2003-06-26 Bamdad Cynthia C. Compositions and methods of treatment of cancer
EP2233472B1 (de) * 2006-03-28 2014-01-15 Atir Holding S.A. Heterocyclische verbindungen und deren verwendung bei der behandlung von sexualstörungen
EP2445343B1 (de) 2009-06-25 2021-08-04 Alkermes Pharma Ireland Limited Prodrugs aus nh-säureverbindungen
CN103517897A (zh) 2010-07-19 2014-01-15 奥尼克斯医药品股份有限公司 环戊二烯并喹唑啉的合成
US20130273034A1 (en) 2010-09-03 2013-10-17 Kenneth W. Bair Novel compounds and compositions for the inhibition of nampt
US9353067B2 (en) 2011-04-10 2016-05-31 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
ES2595240T3 (es) 2012-07-09 2016-12-28 Lupin Limited Derivados de tetrahidroquinazolinona como inhibidores de PARP
US11273158B2 (en) 2018-03-05 2022-03-15 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3069468D1 (en) 1979-12-19 1984-11-22 Nat Res Dev Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
GB8607683D0 (en) 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
GB8707053D0 (en) 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
GB8809978D0 (en) 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
AU640016B2 (en) * 1990-05-30 1993-08-12 Imperial Chemical Industries Plc Hydroquinazoline derivatives
GB9105771D0 (en) 1991-03-19 1991-05-01 Cancer Res Inst Royal Anti-cancer compounds
GB9205320D0 (en) 1992-03-11 1992-04-22 Ici Plc Anti-tumour compounds
GB9220571D0 (en) 1992-09-30 1992-11-11 Ici Plc Quinazoline derivatives
GB9223352D0 (en) 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds

Also Published As

Publication number Publication date
JP2002537391A (ja) 2002-11-05
ATE264322T1 (de) 2004-04-15
ES2219308T3 (es) 2004-12-01
EP1155012A1 (de) 2001-11-21
DE60009868D1 (en) 2004-05-19
GB9904275D0 (en) 1999-04-21
AU2683800A (en) 2000-09-14
AU772670B2 (en) 2004-05-06
US6699861B1 (en) 2004-03-02
WO2000050417A1 (en) 2000-08-31
DE60009868T2 (de) 2005-04-21
CA2364708A1 (en) 2000-08-31
EP1155012B1 (de) 2004-04-14

Similar Documents

Publication Publication Date Title
YU47969B (sh) Postupak za dobijanje derivata pirimidinona kao kalcijum nezavisnih camp inhibitora fosfordiesteraze
MY119238A (en) 8-quinolinzanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
DE69425162D1 (de) 4,5-diaryloxazol-derivate
DK540689A (da) 1,4-diazepinderivater og deres farmaceutiske anvendelse
ES8404990A1 (es) Un procedimiento para la preparacion de derivados de prolina.
ES2014523A6 (es) Procedimiento de preparar derivados de aril-heteroarilcarbinoles.
DK1155012T3 (da) Dihydroquinazolinderivater med anti-cancer-aktivitet
DE69505968D1 (de) Azolidindion-derivate und ihre anwendung als antihyperglykämika
DK0565377T3 (da) Terapeutiske midler til behandling af Parkinsons sygdom
MXPA02006329A (es) 8-arilquinolinas sustituidas que son inhibidores de fosfodiesterasa-4.
KR910007883A (ko) 퀴놀린 유도체, 그의 제조방법 및 용도
MY129935A (en) Dihydropyridine derivatives useful in antitumor therapy
ES2190809T3 (es) Compuestos de quinolina y quinazolina utiles en terapia.
DK382685D0 (da) Tricyclisk oxindolcarboxamid-derivater
ATE197401T1 (de) Chinazolinon-arzneimittel sowie deren verwendung
CO5170520A1 (es) Derivados de 4-(fenil sustituido)-2-piperazinil-pirimidin-(3,5-bistrifluoro-metil-bencil)- metil-amida
TW324009B (en) Pyrazole condensation ring derivative, its production process and its use as androgen inhibitor
BG101601A (en) Pharmaceutical piperazine compounds
DE69122812D1 (de) Glutathionderivat
HUP9904594A2 (hu) Piperazinoszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
IT1191845B (it) Alchiloli derivati farmacologicamente attivi
EP0358432A3 (de) 1,4-Dihydropyridin-Derivate
EP0461264A4 (en) Ethynylphenyl derivative, production thereof, and remedy for diseases of circulatory organs containing the same as active ingredient
MX9710378A (es) Derivados de 4-finilaminotiazol, su proceso de preparacion y las composiciones farmaceuticas que los contienen.
TR200002757T2 (tr) Virüs etkisini önleyici bir aktivitesi olan ındol türevleri